SPARTA, NCT01749787: Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis |
|
|
| Completed | 1 | 61 | US | PRTX-100 at 1.5 mcg/kg, Staphylococcal Protein A, SpA, PRTX-100 at 3.0 mcg/kg, PRTX-100 at 6.0 mcg/kg, PRTX-100 at 12.0 mcg/kg, PRTX-100 at 240 mcg, Placebo, PRTX-100 at 420 mcg | Protalex, Inc. | Arthritis, Rheumatoid | 08/14 | 08/14 | | |